Literature DB >> 16697681

Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.

Anabelle Lefeuvre1, Hugues Contamin, Thierry Decelle, Christophe Fournier, Jean Lang, Vincent Deubel, Philippe Marianneau.   

Abstract

Yellow fever (YF) virus is currently found in tropical Africa and South America, and is responsible for a febrile to severe illness characterized by organ failure and shock. The attenuated YF 17D strain, used in YF vaccine, was derived from the wild-type strain Asibi. Although studies have been done on genetic markers of YF virulence, differentiation of the two strains in terms of host-cell interaction during infection remains elusive. As YF wild-type strains are hepatotropic, we chose a hepatic cell line (HepG2) to study YF virus-host cell interaction. HepG2 cells rapidly produced high titres of infectious viral particles for 17D and Asibi YF strains. However, HepG2 cells were more susceptible to the attenuated 17D virus infection, and only this virus strain induced early apoptosis in these cells. Molecular markers specific for the 17D virus were identified by microarray analysis and confirmed by quantitative RT-PCR analysis. As early as 1h postinfection, three genes, (IEX-1, IRF-1, DEC-1) all implicated in apoptosis pathways, were upregulated. Later in infection (48 h) two other genes (HSP70-1A and 1B), expressed in cases of cellular stress, were highly upregulated in 17D-infected HepG2 cells. The early specific upregulation of these cellular genes in HepG2 cells may be considered markers of the 17D virus. This study on the YF attenuated strain gives a new approach to the analysis of the factors involved in virus attenuation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697681     DOI: 10.1016/j.micinf.2006.01.013

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  15 in total

1.  An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.

Authors:  Matthew K Howe; Brittany L Speer; Philip F Hughes; David R Loiselle; Subhash Vasudevan; Timothy A J Haystead
Journal:  Antiviral Res       Date:  2016-04-04       Impact factor: 5.970

2.  Factors Involved in the Apoptotic Cell Death Mechanism in Yellow Fever Hepatitis.

Authors:  Jeferson da Costa Lopes; Luiz Fábio Magno Falcão; Arnaldo Jorge Martins Filho; Marcos Luiz Gaia Carvalho; Caio Cesar Henriques Mendes; Fábio Alves Olímpio; Vanessa do Socorro Cabral Miranda; Lais Carneiro Dos Santos; Jannifer Oliveira Chiang; Ana Cecilia Ribeiro Cruz; Vanessa Costa Alves Galúcio; Raimunda do Socorro da Silva Azevedo; Lívia Caricio Martins; Maria Irma Seixas Duarte; Jorge Rodrigues de Sousa; Pedro Fernando da Costa Vasconcelos; Juarez Antônio Simões Quaresma
Journal:  Viruses       Date:  2022-06-01       Impact factor: 5.818

3.  Analysis of host- and strain-dependent cell death responses during infectious salmon anemia virus infection in vitro.

Authors:  Berit L Schiøtz; Espen S Baekkevold; Lene C Poulsen; Siri Mjaaland; Tor Gjøen
Journal:  Virol J       Date:  2009-07-01       Impact factor: 4.099

4.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

5.  Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa.

Authors:  Nina K Stock; Hewád Laraway; Ousmane Faye; Mawlouth Diallo; Matthias Niedrig; Amadou A Sall
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

Review 6.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Authors:  Florian Douam; Alexander Ploss
Journal:  Trends Microbiol       Date:  2018-06-19       Impact factor: 17.079

7.  Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus.

Authors:  Melissa A Bourgeois; Nancy D Denslow; Kathy S Seino; David S Barber; Maureen T Long
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

8.  Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.

Authors:  Maria Dolores Fernandez-Garcia; Laurent Meertens; Maxime Chazal; Mohamed Lamine Hafirassou; Ophélie Dejarnac; Alessia Zamborlini; Philippe Despres; Nathalie Sauvonnet; Fernando Arenzana-Seisdedos; Nolwenn Jouvenet; Ali Amara
Journal:  MBio       Date:  2016-02-09       Impact factor: 7.867

9.  The Usefulness of a Duplex RT-qPCR during the Recent Yellow Fever Brazilian Epidemic: Surveillance of Vaccine Adverse Events, Epizootics and Vectors.

Authors:  Alice L N Queiroz; Rafael S Barros; Sandro P Silva; Daniela S G Rodrigues; Ana C R Cruz; Flávia B Dos Santos; Pedro F C Vasconcelos; Robert B Tesh; Bruno T D Nunes; Daniele B A Medeiros
Journal:  Pathogens       Date:  2021-06-03

10.  Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes.

Authors:  Myrna C Bonaldo; Samanta M Mello; Gisela F Trindade; Aymara A Rangel; Adriana S Duarte; Prisciliana J Oliveira; Marcos S Freire; Claire F Kubelka; Ricardo Galler
Journal:  Virol J       Date:  2007-10-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.